MedElevator Войти в исследования
← Поиск публикаций

DOI 10.1016/j.urolonc.2021.08.023

Медицинская библиотека · Urologic oncology · 2021

Continuing acetylsalicylic acid during Robotic-Assisted Radical Cystectomy with intracorporeal urinary diversion does not increase hemorrhagic complications: results from a large multicentric cohort.

Albisinni Simone, Diamand Romain, Mjaess Georges, Assenmacher Gregoire, Assenmacher Christophe, Loos Shirley, Verhoest Gregory, Holz Serge, Naudin Michel, Ploussard Guillaume, Mari Andrea, Di Maida Fabrizio, Minervini Andrea, Aoun Fouad, Tay Andrea, Issa Rami, Roumiguié Mathieu, Bajeot Anne Sophie, Simone Giuseppe, Anceschi Umberto, Umari Paolo, Sridhar Ashwin, Kelly John, Hendricksen Kees, Einerhand Sarah, Sanchez-Salas Rafael, Colomer Anna, Quackels Thierry, Peltier Alexandre, Montorsi Francesco, Briganti Alberto, Pradere Benjamin, Moschini Marco, Roumeguère Thierry

СтатьяПеревод в очереди

Аннотация

OBJECTIVES

To evaluate whether continuing the antiplatelet drug acetylsalicylic acid≤100mg (ASA) during Robotic-assisted radical cystectomy (RARC) with intracorporeal urinary diversion (ICUD) increases the risk of peri-and postoperative hemorrhagic complications and overall morbidity. Indeed, guidelines recommend interrupting antiplatelet therapy before radical cystectomy; however, RARC with ICUD is associated to reduced estimated blood loss and blood transfusions compared to its open counterpart.

METHODS

Data from a multicentric European database were analyzed. All participating centers maintained a prospective database of patients undergoing RARC with ICUD. We identified patients receiving antiplatelet therapy by acetylsalicylic acid ≤100mg. Patients were divided into three groups: those not taking acetylsalicylic acid (no-ASA), those where ASA was continued perioperatively (c-ASA) and those where ASA was interrupted perioperatively (i-ASA). Estimated blood loss and peri-and post-operative transfusions were recorded. Hemorrhagic complications, ischemic, thrombotic and cardiac morbidity was recorded and classified using the Clavien-Dindo score by a senior urologist.

RESULTS

640 patients were analyzed. Patients on acetylsalicylic acid were significantly older and had more comorbidities. No significant difference was found for estimated blood loss between no-ASA, c-ASA and i-ASA (280 vs. 300 vs. 200ml respectively; P = 0.09). Similarly, no significant difference was found for intraoperative (5% vs. 9% vs. 11%; P = 0.07) and postoperative transfusion rate (11% vs. 13% vs. 18%; P = 0.17). Higher ischemic complications were noted in the i-ASA group compared to no-ASA and c-ASA (4% vs. 0.6% vs. 1.4%; P = 0.03). On uni and multivariate logistic regression, continuing acetylsalicylic acid was not significantly associated to either major complications or post-operative transfusions.

CONCLUSIONS

Peri-operative acetylsalicylic acid continuation in RARC with ICUD does not increase hemorrhagic complications. Interrupting acetylsalicylic acid peri-operatively may expose patients to a higher risk of ischemic events.

Для цитирования: Albisinni Simone, Diamand Romain, Mjaess Georges, Assenmacher Gregoire, Assenmacher Christophe, Loos Shirley, Verhoest Gregory, Holz Serge, Naudin Michel, Ploussard Guillaume, Mari Andrea, Di Maida Fabrizio, Minervini Andrea, Aoun Fouad, Tay Andrea, Issa Rami, Roumiguié Mathieu, Bajeot Anne Sophie, Simone Giuseppe, Anceschi Umberto, Umari Paolo, Sridhar Ashwin, Kelly John, Hendricksen Kees, Einerhand Sarah, Sanchez-Salas Rafael, Colomer Anna, Quackels Thierry, Peltier Alexandre, Montorsi Francesco, Briganti Alberto, Pradere Benjamin, Moschini Marco, Roumeguère Thierry. Continuing acetylsalicylic acid during Robotic-Assisted Radical Cystectomy with intracorporeal urinary diversion does not increase hemorrhagic complications: results from a large multicentric cohort.. Urologic oncology. 2021. DOI: 10.1016/j.urolonc.2021.08.023.

Предметные рубрики MeSH

Подготовка и перевод публикации
Обработка статьи · этапы, ошибки и управление
Загрузка состояния…

История · было → стало

Состояние обновляется каждые 5 секунд, пока блок открыт. Процент показывается только там, где известен объём работы. Пауза останавливает продолжение этапа; текущий запрос к источнику может завершиться.

Тип публикации указан по данным источника. Уровень доказательности автоматически не присваивается.